Symbol
| TPD52
| contributors: mct/pgu - updated : 08-01-2013
|
HGNC name
| tumor protein D52
|
HGNC id
| 12005
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| amplification
|  
|  
|
in breast carcinoma | tumoral
|  
|  
| --over
|  
|
in prostate carcinoma | tumoral
|  
|  
| --over
|  
|
overexpressed in testicular germ cell tumours | tumoral
|  
|  
| --over
|  
|
significantly up-regulated in colorectal cancers | tumoral
|  
|  
| --over
|  
|
TPD52 overexpression is a favourable independent prognostic marker of potential value in the management of ovarian carcinoma patients | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| potential biomarker for prostate cancer | |
colorectal cancer | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | prostate | |
regulatory sequence that may be used to restrict expression of therapeutic genes to prostate cancer in the prostate cancer gene therapy |
| | |